Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 481-499

Bentham Science Publishers

Access to resources Recommend Favorite

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

By Massarweh Suleiman  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of Estrogen Target Genes and Growth by Selective Estrogen-Receptor Modulators in Endometrial Cancer Cells

By Dardes R.C.   Schafer J.M.G.   Pearce S.T.   Osipo C.   Chen B.   Jordan V.C.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 498-506

Academic Press

Access to resources Recommend Favorite

Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

By Søiland Håvard   Skaland Ivar   Varhaug Jan Erik   Kørner Hartwig   Janssen Emiel   Gudlaugsson Einar   Baak Jan   Søreide Jon Arne  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 514-521

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor and breast cancer

By Sommer S.   Fuqua S.A.W.  

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 339-352

Academic Press

Access to resources Recommend Favorite